Elarekibep (PRS-060/AZD1402), a new class of inhaled Anticalin medicine targeting IL-4Ra for type 2 endotype asthma.
Saved in:
| Title: | Elarekibep (PRS-060/AZD1402), a new class of inhaled Anticalin medicine targeting IL-4Ra for type 2 endotype asthma. |
|---|---|
| Authors: | Matschiner G; Pieris Pharmaceuticals, Hallbergmoos, Germany. Electronic address: matschiner@pieris.com., Fitzgerald MF; Pieris Pharmaceuticals, Hallbergmoos, Germany., Moebius U; Pieris Pharmaceuticals, Hallbergmoos, Germany., Hohlbaum AM; Pieris Pharmaceuticals, Hallbergmoos, Germany., Gille H; Pieris Pharmaceuticals, Hallbergmoos, Germany., Jensen K; Pieris Pharmaceuticals, Hallbergmoos, Germany., Kirchfeld K; Pieris Pharmaceuticals, Hallbergmoos, Germany., Rattenstetter B; Pieris Pharmaceuticals, Hallbergmoos, Germany., Laforge A; Pieris Pharmaceuticals, Hallbergmoos, Germany., Bel Aiba RS; Pieris Pharmaceuticals, Hallbergmoos, Germany., Ciccotosto J; Lung Health Research Centre, Department of Biochemistry and Pharmacology, University of Melbourne, Parkville, Australia., Nyugen H; Lung Health Research Centre, Department of Biochemistry and Pharmacology, University of Melbourne, Parkville, Australia., Foster ML; Experimental Pathology Consultancy, Benfleet, United Kingdom., Snouwaert JN; University of North Carolina, Chapel Hill, NC., Nguyen M; University of North Carolina, Chapel Hill, NC., Koller BH; University of North Carolina, Chapel Hill, NC., Matis L; Pieris Pharmaceuticals, Boston, Mass., Anderson GP; Lung Health Research Centre, Department of Biochemistry and Pharmacology, University of Melbourne, Parkville, Australia. Electronic address: gpa@unimelb.edu.au., Olwill SA; Pieris Pharmaceuticals, Hallbergmoos, Germany. |
| Source: | The Journal of allergy and clinical immunology [J Allergy Clin Immunol] 2023 Apr; Vol. 151 (4), pp. 966-975. Date of Electronic Publication: 2022 Dec 30. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Mosby Country of Publication: United States NLM ID: 1275002 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6825 (Electronic) Linking ISSN: 00916749 NLM ISO Abbreviation: J Allergy Clin Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 36592703 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Elarekibep (PRS-060/AZD1402), a new class of inhaled Anticalin medicine targeting IL-4Ra for type 2 endotype asthma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Matschiner+G%22">Matschiner G</searchLink>; Pieris Pharmaceuticals, Hallbergmoos, Germany. Electronic address: matschiner@pieris.com.<br /><searchLink fieldCode="AU" term="%22Fitzgerald+MF%22">Fitzgerald MF</searchLink>; Pieris Pharmaceuticals, Hallbergmoos, Germany.<br /><searchLink fieldCode="AU" term="%22Moebius+U%22">Moebius U</searchLink>; Pieris Pharmaceuticals, Hallbergmoos, Germany.<br /><searchLink fieldCode="AU" term="%22Hohlbaum+AM%22">Hohlbaum AM</searchLink>; Pieris Pharmaceuticals, Hallbergmoos, Germany.<br /><searchLink fieldCode="AU" term="%22Gille+H%22">Gille H</searchLink>; Pieris Pharmaceuticals, Hallbergmoos, Germany.<br /><searchLink fieldCode="AU" term="%22Jensen+K%22">Jensen K</searchLink>; Pieris Pharmaceuticals, Hallbergmoos, Germany.<br /><searchLink fieldCode="AU" term="%22Kirchfeld+K%22">Kirchfeld K</searchLink>; Pieris Pharmaceuticals, Hallbergmoos, Germany.<br /><searchLink fieldCode="AU" term="%22Rattenstetter+B%22">Rattenstetter B</searchLink>; Pieris Pharmaceuticals, Hallbergmoos, Germany.<br /><searchLink fieldCode="AU" term="%22Laforge+A%22">Laforge A</searchLink>; Pieris Pharmaceuticals, Hallbergmoos, Germany.<br /><searchLink fieldCode="AU" term="%22Bel+Aiba+RS%22">Bel Aiba RS</searchLink>; Pieris Pharmaceuticals, Hallbergmoos, Germany.<br /><searchLink fieldCode="AU" term="%22Ciccotosto+J%22">Ciccotosto J</searchLink>; Lung Health Research Centre, Department of Biochemistry and Pharmacology, University of Melbourne, Parkville, Australia.<br /><searchLink fieldCode="AU" term="%22Nyugen+H%22">Nyugen H</searchLink>; Lung Health Research Centre, Department of Biochemistry and Pharmacology, University of Melbourne, Parkville, Australia.<br /><searchLink fieldCode="AU" term="%22Foster+ML%22">Foster ML</searchLink>; Experimental Pathology Consultancy, Benfleet, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Snouwaert+JN%22">Snouwaert JN</searchLink>; University of North Carolina, Chapel Hill, NC.<br /><searchLink fieldCode="AU" term="%22Nguyen+M%22">Nguyen M</searchLink>; University of North Carolina, Chapel Hill, NC.<br /><searchLink fieldCode="AU" term="%22Koller+BH%22">Koller BH</searchLink>; University of North Carolina, Chapel Hill, NC.<br /><searchLink fieldCode="AU" term="%22Matis+L%22">Matis L</searchLink>; Pieris Pharmaceuticals, Boston, Mass.<br /><searchLink fieldCode="AU" term="%22Anderson+GP%22">Anderson GP</searchLink>; Lung Health Research Centre, Department of Biochemistry and Pharmacology, University of Melbourne, Parkville, Australia. Electronic address: gpa@unimelb.edu.au.<br /><searchLink fieldCode="AU" term="%22Olwill+SA%22">Olwill SA</searchLink>; Pieris Pharmaceuticals, Hallbergmoos, Germany. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%221275002%22">The Journal of allergy and clinical immunology</searchLink> [J Allergy Clin Immunol] 2023 Apr; Vol. 151 (4), pp. 966-975. <i>Date of Electronic Publication: </i>2022 Dec 30. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Mosby%22">Mosby </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>1275002 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1097-6825 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200916749%22">00916749 </searchLink><i>NLM ISO Abbreviation: </i>J Allergy Clin Immunol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36592703 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.jaci.2022.12.815 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 966 Titles: – TitleFull: Elarekibep (PRS-060/AZD1402), a new class of inhaled Anticalin medicine targeting IL-4Ra for type 2 endotype asthma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Matschiner G – PersonEntity: Name: NameFull: Fitzgerald MF – PersonEntity: Name: NameFull: Moebius U – PersonEntity: Name: NameFull: Hohlbaum AM – PersonEntity: Name: NameFull: Gille H – PersonEntity: Name: NameFull: Jensen K – PersonEntity: Name: NameFull: Kirchfeld K – PersonEntity: Name: NameFull: Rattenstetter B – PersonEntity: Name: NameFull: Laforge A – PersonEntity: Name: NameFull: Bel Aiba RS – PersonEntity: Name: NameFull: Ciccotosto J – PersonEntity: Name: NameFull: Nyugen H – PersonEntity: Name: NameFull: Foster ML – PersonEntity: Name: NameFull: Snouwaert JN – PersonEntity: Name: NameFull: Nguyen M – PersonEntity: Name: NameFull: Koller BH – PersonEntity: Name: NameFull: Matis L – PersonEntity: Name: NameFull: Anderson GP – PersonEntity: Name: NameFull: Olwill SA IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: 2023 Apr Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1097-6825 Numbering: – Type: volume Value: 151 – Type: issue Value: 4 Titles: – TitleFull: The Journal of allergy and clinical immunology Type: main |
| ResultId | 1 |